Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Altimmune, Inc. | Chief Financial Officer | Common Stock, par value $0.0001 | 17.7K | $199K | $11.25 | Jul 31, 2021 | Direct |
ObsEva SA | Interim CEO and CFO | Employee Stock Option (right to buy) | 250K | Feb 23, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
OBSV | ObsEva SA | Feb 23, 2023 | 1 | $0 | 4 | Feb 24, 2023 | Interim CEO and CFO |
OBSV | ObsEva SA | Jan 1, 2023 | 0 | $0 | 3 | Jan 3, 2023 | Chief Financial Officer |
ALT | Altimmune, Inc. | Jul 31, 2021 | 1 | $6.19K | 4 | Aug 6, 2021 | Chief Financial Officer |